Baxter International (BAX) Revenue (2009 - 2026)

Baxter International (BAX) has reported Revenue for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Revenue rose 5.34% year-over-year to $3.0 billion; the TTM figure through Jun 2026 stood at $11.1 billion (up 1.92% YoY), while the FY2025 annual figure was $11.2 billion, up 5.72% from the prior year.
• Revenue grew to $3.0 billion in Q2 2026 per BAX's latest filing, from $2.7 billion in the prior quarter.
• Across five years, Revenue topped out at $3.7 billion in Q4 2022 and bottomed at $2.4 billion in Q1 2023.
• Historically, Revenue has averaged $2.9 billion across 5 years, with a median of $2.7 billion in 2023.
• Annual changes were most pronounced in 2022 — Revenue soared 30.22% — and 2023, when it tumbled 31.39%.
• Baxter International's Revenue stood at $3.7 billion in 2022, then fell by 27.13% to $2.7 billion in 2023, then grew by 0.88% to $2.8 billion in 2024, then rose by 2.07% to $2.8 billion in 2025, then gained by 5.34% to $3.0 billion in 2026.
• Business Quant data shows BAX's Revenue at $3.0 billion in Q2 2026, $2.7 billion in Q1 2026, and $2.8 billion in Q2 2025.